Managing Cancer-Related Fatigue

Many patients feel sick and tired from treatment and their cancer, but there are ways to manage it.

PUBLISHED: 1:00 AM, TUE MARCH 12, 2013
Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.
Fatigue is the most common side effect of cancer and its treatment, and it varies in degree from patient to patient. It can be sporadic or constant, and, in some cases, is more intense and debilitating than “normal” fatigue. At its most intense, it can’t be relieved by sleep and is often described as “paralyzing.” It affects physical, emotional and social quality of life and is characterized by a lack of energy and motivation, total body exhaustion, a feeling of heaviness, an inability to concentrate or remember, and anxiety. Patients should discuss fatigue with their healthcare providers, who can suggest coping mechanisms and solutions, and can help them understand that such exhaustion doesn’t necessarily mean the cancer has worsened or recurred.

Fatigue is experienced by up to 90 percent of cancer patients and is caused by side effects of cancer treatments or by the cancer itself. Like the fatigue, causes vary from person to person and are often due to metabolic changes. Some cancers increase the body’s need for energy, weaken muscles and alter hormone levels. Others release proteins called cytokines, which appear to increase fatigue.

Little is known about cancer-related fatigue, but one cause may be the destruction of healthy cells in addition to those targeted for treatment and the amount of energy needed to repair and heal damaged tissues. Anemia, nausea, vomiting, pain, insomnia and mood change often occur during and after treatment and can lead to extreme fatigue.

The following are common causes of fatigue:

> Chemotherapy, radiation, bone marrow transplantation and surgery, particularly chemotherapies that stop bone marrow from making enough red blood cells to carry oxygen to the body;

> Biologic therapies that use the body’s immune system to fight cancer;

> Treatment-related hormonal changes to thyroid and adrenal glands, testes and ovaries;

> Treatment-related nutrient deficiencies;

> Sleep disorders, anxiety, depression and difficulty learning and remembering (attention fatigue); and

> Medication to treat other conditions and side effects, especially pain.

Following cancer treatment, most survivors want to resume a lifestyle free from cancer-related fatigue. The American Cancer Society estimates, though, that 30 to 50 percent of cancer survivors experience persistent fatigue for months and, sometimes years. It’s important to continue to consult with physicians, as underlying medical conditions that exacerbate the problem can often be treated. While more research is needed in this area, the following are some ways in which symptoms of fatigue can be managed:

> Medications: Stimulants, such as Ritalin (methylphenidate) and modafinil, might help but must be prescribed and monitored by a physician.

> Diet and Nutrition: Small, well-balanced, highprotein meals can provide energy. Ample fluid and limited caffeine and alcohol intake may prevent dehydration.

Talk about this article with other patients, caregivers, and advocates in the General Discussions CURE discussion group.
Special Feature
Share Your Art
Related Articles
Pairing Radiation Oncology and Palliative Care Leads to Better Outcomes
A novel service model allowed for shorter durations of treatment with radiation, fewer unfinished treatments with radiation, shorter hospital stays and increased use of palliative care.
A View From a Young Lung Cancer Survivor: Genomic Testing Provides Hope
To gain a patient's perspective on the Genomics of Young Lung Cancer Study and the importance of genomic testing, we spoke with Corey Wood, a 23-year-old trial participant and lung cancer survivor.
Varubi Represents 'Another Tool in the Toolbox' for CINV
The approval of Varubi was based on data from several phase 3 trials of the agent in more than 2,500 patients receiving various emetogenic chemotherapy agents.
Related Videos
Amanda L. Kong on Seeking a Second Opinion for Breast Cancer Care at a High Volume Hospital
Amanda L. Kong, discusses why patients should consider seeking a second opinion for their breast cancer diagnosis and care at a high volume hospital.
Amanda L. Kong on Breast Cancer Care at High Volume Hospitals
This study sought to identify patterns of breast cancer care at high volume hospitals.
Sharon L. Bober on Sexual Health Changes in Relation to Treatment
Sharon L. Bober, director, Sexual Health Program, Dana-Farber Cancer Institute, discusses changes in sexual health as they relate to different treatments for cancer.